PDB Short entry for 1TFT
HEADER    APOPTOSIS                               27-MAY-04   1TFT              
TITLE     NMR STRUCTURE OF AN ANTAGONISTS OF THE XIAP-CASPASE-9 INTERACTION     
TITLE    2 COMPLEXED TO THE BIR3 DOMAIN OF XIAP                                 
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4;               
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: BIR3 OF XIAP: RESIDUES 241-356;                            
COMPND   5 SYNONYM: INHIBITOR OF APOPTOSIS PROTEIN 3, X-LINKED INHIBITOR OF     
COMPND   6 APOPTOSIS PROTEIN, X-LINKED IAP, IAP-LIKE PROTEIN, HILP;             
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: BIRC4, API3, IAP3, XIAP;                                       
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PET28B                                    
KEYWDS    COMPLEX, LIGAND-PROTEIN, APOPTOSIS, BIR, XIAP                         
EXPDTA    SOLUTION NMR                                                          
MDLTYP    MINIMIZED AVERAGE                                                     
AUTHOR    T.K.OOST,C.SUN,R.C.ARMSTRONG,A.S.AL-ASSAAD,S.F.BETZ,T.L.DECKWERTH,    
AUTHOR   2 S.W.ELMORE,R.P.MEADOWS,E.T.OLEJNICZAK,A.K.OLEKSIJEW,T.OLTERSDORF,    
AUTHOR   3 S.H.ROSENBERG,A.R.SHOEMAKER,H.ZOU,S.W.FESIK                          
REVDAT   3   02-MAR-22 1TFT    1       REMARK SEQADV LINK                       
REVDAT   2   24-FEB-09 1TFT    1       VERSN                                    
REVDAT   1   03-MAY-05 1TFT    0                                                
JRNL        AUTH   T.K.OOST,C.SUN,R.C.ARMSTRONG,A.S.AL-ASSAAD,S.F.BETZ,         
JRNL        AUTH 2 T.L.DECKWERTH,H.DING,S.W.ELMORE,R.P.MEADOWS,E.T.OLEJNICZAK,  
JRNL        AUTH 3 A.K.OLEKSIJEW,T.OLTERSDORF,S.H.ROSENBERG,A.R.SHOEMAKER,      
JRNL        AUTH 4 K.J.TOMASELLI,H.ZOU,S.W.FESIK                                
JRNL        TITL   DISCOVERY OF POTENT ANTAGONISTS OF THE ANTIAPOPTOTIC PROTEIN 
JRNL        TITL 2 XIAP FOR THE TREATMENT OF CANCER.                            
JRNL        REF    J.MED.CHEM.                   V.  47  4417 2004              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   15317454                                                     
JRNL        DOI    10.1021/JM040037K                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 2000                                             
REMARK   3   AUTHORS     : BRUNGER                                              
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1TFT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUN-04.                  
REMARK 100 THE DEPOSITION ID IS D_1000022610.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 303                                
REMARK 210  PH                             : 7.2                                
REMARK 210  IONIC STRENGTH                 : 20MM TRIS                          
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : U-15N, 0.8MM BIR3,20MM TRIS,       
REMARK 210                                   2MMDTT; U-15N,13C 0.8MM BIR3,      
REMARK 210                                   20MM TRIS, 2MMDTT                  
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 3D_13C-SEPARATED_NOESY; 3D_15N     
REMARK 210                                   -SEPARATED_NOESY; 2D_13C,15N       
REMARK 210                                   FILTERED NOESY; 2D_13C,15N         
REMARK 210                                   FILTERED TOCSY; 3D_13C,15N         
REMARK 210                                   FILTERED ,13C SEPARATED NOESY      
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ                            
REMARK 210  SPECTROMETER MODEL             : DRX                                
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : NULL                               
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 210 CONFORMERS, SELECTION CRITERIA  : NULL                               
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ALA A 243       84.17     62.11                                   
REMARK 500    VAL A 244       46.56   -102.47                                   
REMARK 500    SER A 245      -64.61   -171.59                                   
REMARK 500    ASP A 247      -57.18   -164.21                                   
REMARK 500    PHE A 250       72.29     56.83                                   
REMARK 500    ASN A 252      -66.87   -157.98                                   
REMARK 500    SER A 253      -62.70   -177.83                                   
REMARK 500    ASN A 255       99.24    -58.74                                   
REMARK 500    ARG A 258      -62.21   -170.45                                   
REMARK 500    ASN A 259       75.30     58.52                                   
REMARK 500    MET A 262      -50.50   -167.43                                   
REMARK 500    ASP A 264      -62.25   -137.76                                   
REMARK 500    TYR A 277      -50.81   -152.62                                   
REMARK 500    SER A 278      -78.36   -132.92                                   
REMARK 500    ASP A 296      -49.43     83.14                                   
REMARK 500    LYS A 297      101.16    -57.47                                   
REMARK 500    HIS A 302      -66.75     70.74                                   
REMARK 500    TYR A 324       84.72   -157.15                                   
REMARK 500    LEU A 344      -49.29   -167.45                                   
REMARK 500    LEU A 348      176.62     59.67                                   
REMARK 500    GLU A 349       75.62     60.56                                   
REMARK 500    CYS A 351       81.67     59.60                                   
REMARK 500    VAL A 353      -67.41     71.78                                   
REMARK 500    ARG A 354       48.19   -169.93                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 620                                                                      
REMARK 620 METAL COORDINATION                                                   
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):                             
REMARK 620                                                                      
REMARK 620 COORDINATION ANGLES FOR:  M RES CSSEQI METAL                         
REMARK 620                              ZN A 999  ZN                            
REMARK 620 N RES CSSEQI ATOM                                                    
REMARK 620 1 CYS A 300   SG                                                     
REMARK 620 2 CYS A 303   SG  108.7                                              
REMARK 620 3 HIS A 320   ND1 110.1 109.9                                        
REMARK 620 4 CYS A 327   SG  109.2 110.0 109.0                                  
REMARK 620 N                    1     2     3                                   
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 999                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 997 A 998                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1TFQ   RELATED DB: PDB                                   
REMARK 900 ANOTHER ANTAGONIST/BIR3 COMPLEX STRUCTURE                            
REMARK 900 RELATED ID: 1G3F   RELATED DB: PDB                                   
REMARK 900 SMAC PEPTIDE/BIR3 COMPLEX STRUCTURE                                  
DBREF  1TFT A  241   356  UNP    P98170   BIRC4_HUMAN    241    356             
SEQADV 1TFT MET A  240  UNP  P98170              INITIATING METHIONINE          
SEQRES   1 A  117  MET SER ASP ALA VAL SER SER ASP ARG ASN PHE PRO ASN          
SEQRES   2 A  117  SER THR ASN LEU PRO ARG ASN PRO SER MET ALA ASP TYR          
SEQRES   3 A  117  GLU ALA ARG ILE PHE THR PHE GLY THR TRP ILE TYR SER          
SEQRES   4 A  117  VAL ASN LYS GLU GLN LEU ALA ARG ALA GLY PHE TYR ALA          
SEQRES   5 A  117  LEU GLY GLU GLY ASP LYS VAL LYS CYS PHE HIS CYS GLY          
SEQRES   6 A  117  GLY GLY LEU THR ASP TRP LYS PRO SER GLU ASP PRO TRP          
SEQRES   7 A  117  GLU GLN HIS ALA LYS TRP TYR PRO GLY CYS LYS TYR LEU          
SEQRES   8 A  117  LEU GLU GLN LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS          
SEQRES   9 A  117  LEU THR HIS SER LEU GLU GLU CYS LEU VAL ARG THR THR          
HET     ZN  A 999       1                                                       
HET    997  A 998      81                                                       
HETNAM      ZN ZINC ION                                                         
HETNAM     997 1-[3,3-DIMETHYL-2-(2-METHYLAMINO-PROPIONYLAMINO)-                
HETNAM   2 997  BUTYRYL]-4-PHENOXY-PYRROLIDINE-2-CARBOXYLIC ACID(1,2,           
HETNAM   3 997  3,4-TETRAHYDRO-NAPHTHALEN-1-YL)-AMIDE                           
HETSYN     997 N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-               
HETSYN   2 997  TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE                           
FORMUL   2   ZN    ZN 2+                                                        
FORMUL   3  997    C31 H42 N4 O4                                                
HELIX    1   1 ASP A  264  GLY A  273  1                                  10    
HELIX    2   2 ASN A  280  GLY A  288  1                                   9    
HELIX    3   3 ASP A  315  TYR A  324  1                                  10    
HELIX    4   4 CYS A  327  LYS A  334  1                                   8    
HELIX    5   5 LYS A  334  HIS A  343  1                                  10    
SHEET    1   A 3 PHE A 289  ALA A 291  0                                        
SHEET    2   A 3 VAL A 298  CYS A 300 -1  O  LYS A 299   N  TYR A 290           
SHEET    3   A 3 GLY A 306  LEU A 307 -1  O  LEU A 307   N  VAL A 298           
LINK         SG  CYS A 300                ZN    ZN A 999     1555   1555  2.10  
LINK         SG  CYS A 303                ZN    ZN A 999     1555   1555  2.10  
LINK         ND1 HIS A 320                ZN    ZN A 999     1555   1555  2.21  
LINK         SG  CYS A 327                ZN    ZN A 999     1555   1555  2.10  
SITE     1 AC1  4 CYS A 300  CYS A 303  HIS A 320  CYS A 327                    
SITE     1 AC2 11 LYS A 297  LYS A 299  GLY A 306  LEU A 307                    
SITE     2 AC2 11 THR A 308  ASP A 309  LYS A 311  GLU A 314                    
SITE     3 AC2 11 GLN A 319  TRP A 323  TYR A 324                               
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000